Shares of Armata Pharmaceuticals Inc. (ARMP) are rising over 23% in pre-market today, after the biotechnology company announced that it has received a $15 million award for a three year program from the U.S. DoD through the Medical Technology Enterprise Consortium or MTEC with funding from the Defense Health Agency and Joint Warfighter Medical Research Program.
from RTT - Before the Bell https://ift.tt/2Y7DQBi
via IFTTT
No comments:
Post a Comment